JMP Securities assumed coverage on shares of Addus HomeCare (NASDAQ:ADUS – Get Free Report) in a research note issued to investors on Monday,Briefing.com Automated Import reports. The firm set an “outperform” rating and a $150.00 price target on the stock. JMP Securities’ price objective would indicate a potential upside of 20.00% from the company’s previous close.
Several other brokerages have also recently commented on ADUS. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp assumed coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $133.67.
Read Our Latest Analysis on ADUS
Addus HomeCare Trading Up 2.5 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the prior year, the company posted $1.03 earnings per share. Addus HomeCare’s quarterly revenue was up 7.1% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare will post 4.59 EPS for the current year.
Insider Buying and Selling
In related news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Addus HomeCare
Hedge funds have recently made changes to their positions in the stock. Summit Global Investments boosted its holdings in Addus HomeCare by 7.9% in the second quarter. Summit Global Investments now owns 10,752 shares of the company’s stock valued at $1,248,000 after acquiring an additional 790 shares during the last quarter. Louisiana State Employees Retirement System lifted its stake in shares of Addus HomeCare by 2.5% in the 2nd quarter. Louisiana State Employees Retirement System now owns 8,100 shares of the company’s stock valued at $940,000 after purchasing an additional 200 shares in the last quarter. Argent Capital Management LLC grew its holdings in shares of Addus HomeCare by 51.5% during the 2nd quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock worth $4,332,000 after purchasing an additional 12,685 shares during the period. Tributary Capital Management LLC raised its holdings in Addus HomeCare by 0.3% in the second quarter. Tributary Capital Management LLC now owns 208,370 shares of the company’s stock valued at $24,194,000 after buying an additional 609 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in Addus HomeCare by 4.8% during the second quarter. Bank of New York Mellon Corp now owns 129,449 shares of the company’s stock valued at $15,030,000 after buying an additional 5,952 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
- Five stocks we like better than Addus HomeCare
- How to invest in marijuana stocks in 7 steps
- Signal Boost: 2 Key Satellite Stocks Driving Industry Growth
- Insider Trades May Not Tell You What You Think
- CRM Stocks Are Hot in 2024 — Should You Hold for 2025 Gains?
- Why Are These Companies Considered Blue Chips?
- 2 Semiconductor Stocks That Could Break Out in 2025
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.